These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 10385662)

  • 21. A multi-center open study to determine the effect of lamivudine on HBV DNA clearance and to assess the safety of the regimen in patients with chronic hepatitis B infection.
    Mazur W; Król F; Cianciara J; Nazzal K; Gładysz A; Juszczyk J; Bolewska B; Adamek J; Czajka B; Swietek K; Kryczka W; Gonciarz Z
    Med Sci Monit; 2002 Apr; 8(4):CR257-62. PubMed ID: 11951067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A 24-week, parallel-group, open-label, randomized clinical trial comparing the early antiviral efficacy of telbivudine and entecavir in the treatment of hepatitis B e antigen-positive chronic hepatitis B virus infection in adult Chinese patients.
    Zheng MH; Shi KQ; Dai ZJ; Ye C; Chen YP
    Clin Ther; 2010 Apr; 32(4):649-58. PubMed ID: 20435234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective randomized controlled trial of sequential treatment with corticoids and alpha-interferon versus treatment with interferon alone in patients with chronic active hepatitis B.
    Niederau C; Heintges T; Niederau M; Stremmel W; Strohmeyer G
    Eur J Med; 1992 Nov; 1(7):396-402. PubMed ID: 1341478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of tenofovir disoproxil fumarate in hepatitis B e antigen-positive patients with normal levels of alanine aminotransferase and high levels of hepatitis B virus DNA.
    Chan HL; Chan CK; Hui AJ; Chan S; Poordad F; Chang TT; Mathurin P; Flaherty JF; Lin L; Corsa A; Gaggar A; Subramanian GM; McHutchison JG; Lau G; Lee S; Gane EJ
    Gastroenterology; 2014 May; 146(5):1240-8. PubMed ID: 24462735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B.
    Hadziyannis SJ; Tassopoulos NC; Heathcote EJ; Chang TT; Kitis G; Rizzetto M; Marcellin P; Lim SG; Goodman Z; Ma J; Arterburn S; Xiong S; Currie G; Brosgart CL;
    N Engl J Med; 2005 Jun; 352(26):2673-81. PubMed ID: 15987916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B.
    van Zonneveld M; Honkoop P; Hansen BE; Niesters HG; Darwish Murad S; de Man RA; Schalm SW; Janssen HL
    Hepatology; 2004 Mar; 39(3):804-10. PubMed ID: 14999700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B.
    Niederau C; Heintges T; Lange S; Goldmann G; Niederau CM; Mohr L; Häussinger D
    N Engl J Med; 1996 May; 334(22):1422-7. PubMed ID: 8618580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
    Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
    Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retreatment with higher dose interferon alpha in children with chronic hepatitis B infection.
    Ozen H; Koçak N; Yüce A; Gürakan F
    Pediatr Infect Dis J; 1999 Aug; 18(8):694-7. PubMed ID: 10462338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiviral effect of prolonged intermittent lymphoblastoid alpha interferon treatment in chronic hepatitis B.
    Janssen HL; Berk L; Schalm SW; Heijtink RA; Hess G; Rossol S; Meyer zum Buschenfelde KH; Chamuleau RA; Jansen PL; Reesink HW
    Gut; 1992 Aug; 33(8):1094-8. PubMed ID: 1398234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination alpha-interferon and lamivudine therapy for alpha-interferon-resistant chronic hepatitis B infection: results of a pilot study.
    Mutimer D; Naoumov N; Honkoop P; Marinos G; Ahmed M; de Man R; McPhillips P; Johnson M; Williams R; Elias E; Schalm S
    J Hepatol; 1998 Jun; 28(6):923-9. PubMed ID: 9672165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized controlled trial of kurorinone versus interferon-alpha2a treatment in patients with chronic hepatitis B.
    Chen C; Guo SM; Liu B
    J Viral Hepat; 2000 May; 7(3):225-9. PubMed ID: 10849265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A clinical study of the efficacy and safety of secretory human interferon alpha-2a treatment for chronic hepatitis B].
    Wang H; Wang QH; Wang HF; Jia JD; Xie W; Qin XQ
    Zhonghua Gan Zang Bing Za Zhi; 2004 Oct; 12(10):589-92. PubMed ID: 15504287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of conventional interferon-α in patients with HBeAg-positive chronic hepatitis B: a systematic review and meta-analysis.
    Sun X; Qin W; Zhou R; Wang L; Li Y; Zhao L
    J Evid Based Med; 2010 Nov; 3(4):220-5. PubMed ID: 21349073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon-alpha therapy for chronic hepatitis B: early response related to pre-treatment changes in viral replication.
    Heijtink RA; Janssen HL; Hop WC; Osterhaus AD; Schalm SW
    J Med Virol; 2001 Mar; 63(3):217-9. PubMed ID: 11170060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polyunsaturated phosphatidyl-choline and interferon alpha for treatment of chronic hepatitis B and C: a multi-center, randomized, double-blind, placebo-controlled trial. Leich Study Group.
    Niederau C; Strohmeyer G; Heintges T; Peter K; Göpfert E
    Hepatogastroenterology; 1998; 45(21):797-804. PubMed ID: 9684137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective trial of recombinant leucocyte interferon in chronic hepatitis B: a 10-month follow-up study.
    Coppens JP; Cornu C; Lens E; Lamy M; Geubel A
    Liver; 1989 Oct; 9(5):307-13. PubMed ID: 2685491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term follow-up of a randomized trial of interferon therapy for chronic hepatitis B in a predominantly homosexual male population.
    Chen DK; Yim C; O'Rourke K; Krajden M; Wong DK; Heathcote EJ
    J Hepatol; 1999 Apr; 30(4):557-63. PubMed ID: 10207795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon-alpha2b therapy is efficacious in Asian-Americans with chronic hepatitis B infection: a prospective controlled trial.
    Martin P; Hann HW; Westerberg S; Muñoz SJ; Rubin R; Maddrey WC
    Dig Dis Sci; 1998 Apr; 43(4):875-9. PubMed ID: 9580255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and efficacy of interferon retreatment in children with chronic hepatitis B.
    Ballauff A; Schneider T; Gerner P; Habermehl P; Behrens R; Wirth S
    Eur J Pediatr; 1998 May; 157(5):382-5. PubMed ID: 9625334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.